Treatment of these cell lines with 5-aza-dC resulted in ABCG2 promoter demethylation, upregulation of ABCG2 and decreased anti-cancer drug sensitivity, indicating that in these cell lines, ABCG2 promoter methylation played a role in ABCG2 gene regulation. This evidence concerns the gene ABCG2 and cancer.